Northwest Biotherapeutics Cash Flow Statement (2010-2026) | NWBO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-13.21M	-11.65M	-11.83M	-14.19M	-22.53M	-130.24M	-19.45M	-13.99M	-14.88M	-15.53M	-11.99M	-17.26M	-19.16M	-16.88M	-26.23M	-18.91M	-24.75M	-16.94M	-16.13M	-13.25M
Depreciation and Depletion (Quarter)				0.10M	0.50M	0.30M	0.40M	0.30M	0.40M	0.40M	0.40M	0.40M	0.50M			0.40M				0.60M
Share-based Compensation (Quarter)	3.55M	1.26M	0.87M	0.62M	5.76M	3.36M	2.56M	0.93M	0.28M	1.62M	1.57M	1.16M	1.15M	-1.95M		0.39M	0.36M	0.27M	0.18M	0.29M
Asset Writedowns and Impairment (Quarter)																				0.31M
Non-cash Items (Quarter)	-13.45M	-56.38M	-143.87M	0.64M	11.41M	16.96M	16.04M	-0.53M	1.69M	9.46M	2.04M	2.63M	0.84M	7.34M	5.95M	3.54M	3.82M	10.29M	-15.22M	-7.55M
Cash from Operations (Quarter)	-6.79M	-7.01M	-11.25M	-12.97M	-14.84M	-16.12M	-8.85M	-11.24M	-11.52M	-13.92M	-16.96M	-12.41M	-16.20M	-8.23M	-20.18M	-9.42M	-6.69M	-13.89M	-14.76M	-12.51M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)						0.06M		0.07M	0.07M	0.07M		0.08M	0.08M	0.08M	0.06M	0.06M	0.07M	0.07M	0.07M	0.08M
Depreciation & Amortization (CF) (Quarter)	0.08M	0.10M	0.08M	0.10M	0.52M	0.31M	0.32M	0.34M	0.35M	0.42M	0.42M	0.43M	0.43M	0.45M	0.44M	0.43M	0.45M	0.45M	0.73M	0.77M
Change in Working Capital
Change in Account Payables (Quarter)	0.48M	0.80M	1.17M	-0.69M	2.75M	0.07M	1.23M	-0.34M	-0.06M	-1.83M	-2.24M	-0.81M	-0.25M	0.56M	1.41M	2.02M	1.54M	1.82M	0.55M	-0.36M
Change in Accured Expenses (Quarter)	0.55M	0.93M	-2.27M	0.80M	0.74M	-0.28M	2.24M	0.97M	1.23M	0.45M	-2.61M	4.53M	0.66M	3.34M	0.40M	4.38M	3.16M	1.32M	-1.10M	0.89M
Other Working Capital Changes (Quarter)	-0.04M
Investing Activities
Capital Expenditures (Quarter)	1.51M	2.69M	1.55M	0.06M	0.41M	0.28M	2.16M	1.33M	1.25M	0.44M	0.42M	0.24M	0.52M	0.18M	0.08M	0.09M	0.30M	0.20M	0.91M	0.13M
Acquisitions (Quarter)
Cash from Investing Activities (Quarter)	-1.51M	-2.69M	-1.55M	-0.06M	-0.41M	-0.28M	-2.16M	-1.33M	-1.25M	-0.44M	-0.42M	-0.24M	-0.52M	-0.18M	-0.08M	-0.09M	-0.30M	-0.51M	-0.91M	-0.13M
Financing Activities
Other financing activities (Quarter)	3.33M	8.04M	7.87M	4.18M	5.37M	0.43M	1.11M	0.25M	1.32M	0.03M	0.12M	1.31M	0.18M	0.03M	0.02M	0.02M	0.01M			0.01M
Cash from Financing Activities (Quarter)	4.78M	8.92M	23.67M	3.92M	10.41M	16.29M	11.35M	12.58M	8.64M	17.12M	14.41M	12.09M	17.14M	11.62M	15.94M	11.73M	12.45M	11.56M	13.59M	9.21M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)							7.76M	2.38M	2.37M	5.14M	3.43M	3.62M	-0.73M	7.11M	-1.81M	5.12M	7.28M	4.90M	2.02M	2.90M
Additional items
Exchange Rate Effect (Quarter)	-0.19M	0.86M	0.46M	0.90M	2.71M	4.70M	-2.80M	-0.78M	-0.64M	1.91M	-1.01M	0.91M	-0.02M	-3.15M	3.55M	-1.62M	-3.92M	3.09M	0.56M	2.17M
Change in Cash (Quarter)	-3.71M	0.08M	11.33M	-8.21M	-2.13M	4.59M	-2.46M	-0.77M	-4.77M	4.67M	-3.97M	0.35M	0.40M	0.06M	-0.76M	0.60M	1.54M	0.24M	-1.52M	-1.25M
Free Cash Flow (Quarter)	-8.30M	-9.70M	-12.80M	-13.03M	-15.25M	-16.39M	-11.01M	-12.57M	-12.77M	-14.36M	-17.38M	-12.64M	-16.72M	-8.41M	-20.26M	-9.51M	-6.99M	-14.10M	-15.67M	-12.64M
Net Cash Flow (Quarter)	-3.52M	-0.78M	10.87M	-9.11M	-4.84M	-0.11M	0.34M	0.01M	-4.13M	2.77M	-2.96M	-0.56M	0.42M	3.21M	-4.32M	2.22M	5.46M	-2.85M	-2.08M	-3.43M

Research Tools

Developers

Northwest Biotherapeutics Cash Flow Statement (2010-2026) | NWBO

Research Tools

Developers

Northwest Biotherapeutics Cash Flow Statement (2010-2026) | NWBO

Create an account

Sign In

Reset Password